The FDA is moving at lightning speed to review Eisai Co Ltd’s and Biogen Inc’s potential breakthrough drug for Alzheimer’s. Dubbed lecanemab, this antibody therapy could be a game-changer, much like its predecessor Aduhelm. The FDA has announced that a decision will be made on January 6, 2023, providing hope for those suffering from Alzheimer’s and their loved ones. This accelerated review shows the urgent need for effective treatments in the fight against this devastating disease. If approved, lecanemab could revolutionize our approach to treating Alzheimer’s by targeting the underlying causes rather than just managing symptoms. With this exciting news, it’s important to delve into the research behind lecanemab and comprehend the science behind the potential breakthrough. Stay tuned for updates as we eagerly await the FDA decision!
The U.S. Food and Drug Administration will expedite its review of Eisai Co Ltd’s and Biogen Inc’s experimental Alzheimer’s drug lecanemab, with a decision due by Jan 6, 2023, the companies said on Tuesday. Lecanemab, like the partners’ previous drug Aduhelm, is an antibody…
Dr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped potential of the human mind, Dr. Lowemann has dedicated his career to pushing the boundaries of human capabilities and understanding.
Armed with a Master of Science degree and a Ph.D. in his field, Dr. Lowemann has consistently been at the forefront of research and innovation, delving into ways to optimize human performance, cognition, and overall well-being. His work at the Institute revolves around a profound commitment to harnessing cutting-edge science and technology to help individuals lead more fulfilling and intelligent lives.
Dr. Lowemann’s influence extends to the educational platform BetterSmarter.me, where he shares his insights, findings, and personal development strategies with a broader audience. His ongoing mission is shaping the way we perceive and leverage the vast capacities of the human mind, offering invaluable contributions to society’s overall success and collective well-being.